Cargando…

Real-World Analysis of Clinical Characteristics, Treatment Patterns, and Patient-Reported Outcomes of Insufficient Responders and Responders to Prescribed Acute Migraine Treatment in China

INTRODUCTION: Migraine is a common disabling primary headache disorder characterized by attacks of severe pain, sometimes accompanied by symptoms including nausea and photo-/phono-phobia. Real-world data of patients with migraine who sufficiently (responders) and insufficiently (insufficient respond...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Lei, Novick, Diego, Zhong, Shiying, Li, Jinnan, Walker, Chloe, Harrison, Lewis, Jackson, James, Barlow, Sophie, Cotton, Sarah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199977/ https://www.ncbi.nlm.nih.gov/pubmed/36944864 http://dx.doi.org/10.1007/s40122-023-00494-1

Ejemplares similares

A Real‐World Analysis of Patient Characteristics, Treatment Patterns, and Level of Impairment in Patients With Migraine Who are Insufficient Responders vs Responders to Acute Treatment
por: Lombard, Louise, et al.
Publicado: (2020)

Real-World Treatment Patterns and Outcomes Among Patients with Episodic Migraine in China: Results from the Adelphi Migraine Disease Specific Programme™
por: Zhao, Hongru, et al.
Publicado: (2023)

Factors associated with insufficient response to acute treatment of migraine in Japan: analysis of real-world data from the Adelphi Migraine Disease Specific Programme
por: Hirata, Koichi, et al.
Publicado: (2020)

Effect of switching to erenumab in non-responders to a CGRP ligand antibody treatment in migraine: A real-world cohort study
por: Overeem, Lucas Hendrik, et al.
Publicado: (2023)

Unmet Needs in Japanese Patients Who Report Insufficient Efficacy with Triptans for Acute Treatment of Migraine: Retrospective Analysis of Real-World Data
por: Hirata, Koichi, et al.
Publicado: (2020)

Brain Changes in Responders vs. Non-Responders in Chronic Migraine: Markers of Disease Reversal
por: Hubbard, Catherine S., et al.
Publicado: (2016)

The Authors Respond
por: Barlow, Stephen
Publicado: (2010)

Comparative Transcriptional Analysis of Patient Responders Versus Non-Responders to Glucocorticoid Treatment for Bronchopulmonary Dysplasia
por: Shi, Victoria J, et al.
Publicado: (2021)

The Relationship of Insufficient Effort Responding and Response Styles: An Online Experiment
por: Alarcon, Gene M., et al.
Publicado: (2022)

Clinical evaluation of super-responders vs. non-responders to CGRP(-receptor) monoclonal antibodies: a real-world experience
por: Raffaelli, Bianca, et al.
Publicado: (2023)

Real-world treatment patterns and patient-reported outcomes in episodic and chronic migraine in Japan: analysis of data from the Adelphi migraine disease specific programme
por: Ueda, Kaname, et al.
Publicado: (2019)

Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPT
por: Silberstein, Stephen D, et al.
Publicado: (2015)

Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II randomized trials
por: Lipton, Richard B., et al.
Publicado: (2022)

The percent of chronic migraine patients who responded to onabotulinumtoxinA treatment per treatment cycle in the PREEMPT clinical program
por: Silberstein, S, et al.
Publicado: (2013)

A global real-world assessment of the impact on health-related quality of life and work productivity of migraine in patients with insufficient versus good response to triptan medication
por: Lombard, Louise, et al.
Publicado: (2020)

Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium
por: Neesgaard, Bastian, et al.
Publicado: (2020)

Characterizing Treatment Non-responders vs. Responders in Completed Alzheimer’s Disease Clinical Trials
por: Wang, Dulin, et al.
Publicado: (2023)

Treatment modalities for poor ovarian responders
por: Di Guardo, Federica, et al.
Publicado: (2023)

Locked-in syndrome responding to endovascular treatment
por: Song, Jiaxing, et al.
Publicado: (2023)

NIEHS responds to World Trade Center attacks.
por: Manuel, J S
Publicado: (2001)

Responding to priority health challenges in the Arab world
por: Alwan, Ala
Publicado: (2014)

The cholera challenge: How should the world respond?
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2022)

Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD
por: Fassnacht-Riederle, Heidi, et al.
Publicado: (2014)

Transcriptomic and Lipidomic Profiles in Nasal Polyps of Glucocorticoid Responders and Non-Responders: Before and After Treatment
por: Zhu, Zhenzhen, et al.
Publicado: (2022)

Efficacy of prescribed injectable diacetylmorphine in the Andalusian trial: Bayesian analysis of responders and non-responders according to a multi domain outcome index
por: Perea-Milla, Emilio, et al.
Publicado: (2009)

A real-world analysis of patient-reported outcomes in patients with migraine by preventive treatment eligibility status in the US and Europe
por: Ford, Janet H., et al.
Publicado: (2020)

To respond or not to respond: exploring empathy-related psychological and structural brain differences between placebo analgesia responders and non-responders
por: Hartmann, Helena, et al.
Publicado: (2023)

Respondent
por: Mitchell, Samuel A.
Publicado: (1992)

Pharmacokinetics of sumatriptan in non-respondent and in adverse drug reaction reporting migraine patients
por: Sternieri, E., et al.
Publicado: (2005)

Cilostazol induced migraine does not respond to sumatriptan in a double blind trial
por: Falkenberg, Katrine, et al.
Publicado: (2018)

To respond or not to respond, the recurring question in plant mechanosensitivity
por: Leblanc-Fournier, Nathalie, et al.
Publicado: (2014)

An empirically generated responder definition for rosacea treatment
por: Staedtler, Gerald, et al.
Publicado: (2017)

Nanomaterials Respond to Lysosomal Function for Tumor Treatment
por: Tian, Xuexia, et al.
Publicado: (2022)

Differentiating Responders and Non-responders to rTMS Treatment for Disorder of Consciousness Using EEG After-Effects
por: He, Renhong, et al.
Publicado: (2020)

Baseline EEG-correlates of responders/non-responders to combined antidepressive treatment including transcranial magnetic stimulation
por: Iznak, E., et al.
Publicado: (2021)

Changes in Cerebral Blood Flow after Erenumab Treatment in Good and Non-Responders—A Pilot Study of Migraine Patients
por: Nowaczewska, Magdalena, et al.
Publicado: (2021)

The authors respond to letters on using prescribed psychostimulants to treat stimulant use disorder
por: Palis, Heather N., et al.
Publicado: (2023)

An Atypical Presentation of Pediatric Acute Neuropsychiatric Syndrome Responding to Plasmapheresis Treatment
por: Barzman, Drew H., et al.
Publicado: (2018)

Responding to the challenge of antibiotic resistance: World Health Organization
por: Shrivastava, Saurabh R., et al.
Publicado: (2018)

USA stockpiling of remdesivir: How should the world respond?
por: Dawoud, Dalia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cgqh0cc0hh3u0puon0ds04rj4r